U.S. flag

An official website of the United States government

NM_020708.5(SLC12A5):c.2876C>T (p.Thr959Met) AND Developmental and epileptic encephalopathy, 34

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 31, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001056956.4

Allele description

NM_020708.5(SLC12A5):c.2876C>T (p.Thr959Met)

Gene:
SLC12A5:solute carrier family 12 member 5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
20q13.12
Genomic location:
Preferred name:
NM_020708.5(SLC12A5):c.2876C>T (p.Thr959Met)
HGVS:
  • NC_000020.11:g.46056238C>T
  • NG_046341.1:g.39549C>T
  • NM_001134771.2:c.2945C>T
  • NM_020708.5:c.2876C>TMANE SELECT
  • NP_001128243.1:p.Thr982Met
  • NP_065759.1:p.Thr959Met
  • NC_000020.10:g.44684877C>T
  • NM_001134771.1:c.2945C>T
  • NM_020708.4:c.2876C>T
Protein change:
T959M
Links:
dbSNP: rs759314815
NCBI 1000 Genomes Browser:
rs759314815
Molecular consequence:
  • NM_001134771.2:c.2945C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020708.5:c.2876C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Developmental and epileptic encephalopathy, 34 (DEE34)
Synonyms:
Early infantile epileptic encephalopathy 34
Identifiers:
MONDO: MONDO:0014718; MedGen: C4225257; Orphanet: 293181; OMIM: 616645

Recent activity

Clear Turn Off Turn On
  • peat metagenome
    peat metagenome
    Peat soil microbial communities from Stordalen Mire, Sweden - 719 S1 1-5 metagenome
    BioProject
  • Single cell transcriptome and surface protein expression analysis identify OX40+...
    Single cell transcriptome and surface protein expression analysis identify OX40+GITR+ pathogenic T helper 17 in anklyosing spondilytis [scRNA-seq]
    Single cell transcriptome and surface protein expression analysis identify OX40+GITR+ pathogenic T helper 17 in anklyosing spondilytis [scRNA-seq]
    BioProject
  • Single cell transcriptome and surface protein expression analysis identify OX40+...
    Single cell transcriptome and surface protein expression analysis identify OX40+GITR+ pathogenic T helper 17 in anklyosing spondilytis [CITE-seq]
    Single cell transcriptome and surface protein expression analysis identify OX40+GITR+ pathogenic T helper 17 in anklyosing spondilytis [CITE-seq]
    BioProject
  • IkappaBzeta Controls IL-17-triggered Gene Expression Program in Intestinal Epith...
    IkappaBzeta Controls IL-17-triggered Gene Expression Program in Intestinal Epithelial Cells that Prevents Expansion of SFB and Attenuates Autoimmune Disorders [jejunum]
    IkappaBzeta Controls IL-17-triggered Gene Expression Program in Intestinal Epithelial Cells that Prevents Expansion of SFB and Attenuates Autoimmune Disorders [jejunum]
    BioProject

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001221423Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Uncertain significance
(Aug 31, 2022) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV001221423.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 959 of the SLC12A5 protein (p.Thr959Met). This variant is present in population databases (rs759314815, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SLC12A5-related conditions. ClinVar contains an entry for this variant (Variation ID: 852365). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC12A5 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 5, 2023